Cargando…

Preventive and Predictive Genetics: Towards Personalised Medicine

Traditionally, medical research comprised of the identification of the pathological causes of a disease, its epidemiology and empirical investigation of treatment response. Intensive genetic research, marked by the completion of the human genome project in 2003, heralded a new era in medical researc...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Grech, Godfrey (Editor ), Grossman, Iris (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edición:1st ed. 2015.
Colección:Advances in Predictive, Preventive and Personalised Medicine, 9
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-15344-5
003 DE-He213
005 20230810184254.0
007 cr nn 008mamaa
008 150624s2015 sz | s |||| 0|eng d
020 |a 9783319153445  |9 978-3-319-15344-5 
024 7 |a 10.1007/978-3-319-15344-5  |2 doi 
050 4 |a R850.A1-854 
050 4 |a QH315-320 
072 7 |a MBGR  |2 bicssc 
072 7 |a SCI049000  |2 bisacsh 
072 7 |a MBGR  |2 thema 
082 0 4 |a 610.72  |2 23 
245 1 0 |a Preventive and Predictive Genetics: Towards Personalised Medicine  |h [electronic resource] /  |c edited by Godfrey Grech, Iris Grossman. 
250 |a 1st ed. 2015. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a XX, 378 p. 18 illus., 8 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Predictive, Preventive and Personalised Medicine,  |x 2211-3509 ;  |v 9 
505 0 |a Introduction -- Preventive and Predictive Genetics: A perspective -- Roadmap to Drug Development Enabled by Pharmacogenetics -- Preventative and Predictive Genetics: Towards Personalised Medicine -- Pharmacokinetics and Pharmacogenetics: bringing the magic bullet closer to reality -- Pharmacogenetics of Adverse Drug Reactions -- Pharmacogenomics for haemoglobinopathies therapeutics -- Pharmacogenetics of Neurodegenerative Disorders -- Pharmacogenetics of asthma -- Pharmacogenetics and antineoplastic therapies -- Pharmacogenetics of coumarin anticoagulant therapy -- Implementation of Genomic Medicine: tools and challenges -- Ethical Considerations in the Genomic Era -- Index. 
520 |a Traditionally, medical research comprised of the identification of the pathological causes of a disease, its epidemiology and empirical investigation of treatment response. Intensive genetic research, marked by the completion of the human genome project in 2003, heralded a new era in medical research. While epidemiology and gross pathology are still mainstay useful tools, genetics and genomics have gradually been shown to increase the resolution of drug response research, showing great potential in also informing and identifying the role of genes and their encoded products in the pathophysiology of diseases. This information is already being applied in the prevention of illness, effective early diagnosis, better risk assessment (prognosis), as well as targeted effective and safe treatment allocation (prediction and monitoring). Genetic testing and genomics support personalised medicine by translating genome-based knowledge into clinical practice, offering enhanced benefit for patients and health-care systems at large. Current routine practice for diagnosing and treating patients is conducted by correlating parameters such as age, gender and weight with risks and expected treatment outcomes. In the new era of personalised medicine the healthcare provider is equipped with improved ability to prevent, diagnose, treat and predict outcomes on the basis of complex information sources, including genetic and genomic data. Targeted therapy and reliable prediction of expected outcomes offer patients access to better healthcare management, by way of identifying the therapies effective for the relevant patient group, avoiding prescription of unnecessary treatment and reducing the likelihood of developing adverse drug reactions. 
650 0 |a Medicine  |x Research. 
650 0 |a Biology  |x Research. 
650 0 |a Medical education. 
650 0 |a Bioinformatics. 
650 0 |a Medical genetics. 
650 0 |a Pharmacology. 
650 0 |a Medical microbiology. 
650 1 4 |a Biomedical Research. 
650 2 4 |a Medical Education. 
650 2 4 |a Computational and Systems Biology. 
650 2 4 |a Medical Genetics. 
650 2 4 |a Pharmacology. 
650 2 4 |a Medical Microbiology. 
700 1 |a Grech, Godfrey.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Grossman, Iris.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319153452 
776 0 8 |i Printed edition:  |z 9783319153438 
776 0 8 |i Printed edition:  |z 9783319380575 
830 0 |a Advances in Predictive, Preventive and Personalised Medicine,  |x 2211-3509 ;  |v 9 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-319-15344-5  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)